Detalhe da pesquisa
1.
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Lancet Oncol
; 21(1): 145-161, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786124
2.
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.
J Clin Oncol
; 28(22): 3623-9, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20606092
3.
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study.
Cancer
; 115(8): 1765-75, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19170226
4.
Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
J Clin Oncol
; 25(5): 501-6, 2007 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17290057
5.
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.
J Clin Oncol
; 24(22): 3678-85, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16877737